New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
08:03 EDTRHHBYGenentech, RQx Pharmaceuticals announce drug discovery collaboration
RQx Pharmaceuticals announced that it has entered into a drug discovery collaboration with Genentech, a member of the Roche Group, for the discovery and development of novel drug compounds for an undisclosed target. Under the terms of the agreement, RQx will receive an up-front payment and is eligible to receive research and development milestone payments totaling $111M. In addition, RQx is eligible to receive royalties on sales of products resulting from the collaboration.
News For RHHBY From The Last 14 Days
Check below for free stories on RHHBY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
June 19, 2013
10:46 EDTRHHBYAlexion mentioned as possible target for Roche in London Times
Reference Link
08:45 EDTRHHBYLeerink's biotech analyst holds analyst/industry conference call on ADA
Analyst Antlaffy, along with Dr. George Grunberger, founder & Chairman of the Grunberger Diabetes Institute, preview the upcoming American Diabetes Association's conference, including perspectives on new devices in diabetes, potential disruptive technologies at ADA and progress towards the artificial pancreas on an Analyst/Industry conference call to be held on June 20 at 2 pm.
June 13, 2013
11:02 EDTRHHBYLeerink's major pharma analyst holds an analyst/Industry conference call
Subscribe for More Information
June 11, 2013
08:01 EDTRHHBYLeerink's major pharma and biotech analysts hold a conference call
Subscribe for More Information
June 10, 2013
07:40 EDTRHHBYLeerink's biotech analyst holds analyst/industry conference call on ASCO
Subscribe for More Information
07:24 EDTRHHBYEuropean Society of Human Genetics to host a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use